Clik here to view.
Cell Therapy Ltd. Grants Japan License To Daiichi Sankyo For Its Heart...
CARDIFF, Wales Cell Therapy Ltd. (CTL) today announced the granting of the Japan license for its innovative cardiac regeneration medicine, Heartcel™ (immuno-modulatory progenitor [iMP] cells) to...
View ArticleClik here to view.
サンバイオ、再生細胞薬SB623の網膜変性疾患用途特許を取得
米国カリフォルニア州マウンテンビュー （ビジネスワイヤ） — 再生細胞薬の開発・製造を手掛ける当社グループ（サンバイオ株式会社およびその子会社であるSanBio...
View ArticleClik here to view.
SanBio Granted Key Patent in Treatment for Macular Degeneration
MOUNTAIN VIEW, Calif. SanBio, Inc., a scientific leader in regenerative medicine, today announced it has been granted a key patent by the United States Patent and Trademark Office (USPTO) covering...
View ArticleClik here to view.
European Scleroderma Trial Investigating Cytori Cell Therapy to Be Presented...
SAN DIEGO & TOKYO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that on May 18, 2016, an update regarding the French SCLERADEC I and II clinical trials investigating the use of Cytori...
View ArticleClik here to view.
BioCision to Showcase ThawSTAR CB Thawing System for Cryobags at ISCT 2016
SAN RAFAEL, Calif. BioCision, LLC, a life science research and development company that standardizes processes from research through point-of-care, announced today that they will be showcasing their...
View ArticleClik here to view.
HemaCare Attends Cell Therapy Meeting in Singapore
LOS ANGELES HemaCare Corporation,(OTCBB:HEMA) a leader in cell and tissue collection, processing and cell therapy solutions, today announced that it will be attending the ISCT meeting May 25-28th at...
View ArticleClik here to view.
Biological Industries Announces Poster Presentation at International Society...
KIBBUTZ BEIT HAEMEK, Israel & CROMWELL, Conn. Biological Industries (“BI”; www.bioind.com), a leading developer and manufacturer of cell culture media, molecular biology tools, human...
View ArticleClik here to view.
脳梗塞を対象とした米国フェーズ1/2a試験の投与後12ヵ月経過時の結果をStroke誌に発表
米国カリフォルニア州マウンテンビュー （ビジネスワイヤ）―神経系疾患を対象に再生細胞薬の開発・製造を手掛ける当社グループ（サンバイオ株式会社及びその子会社であるSanBio, Inc.） は、今般、American Heart...
View ArticleClik here to view.
Cytori Cell Therapy Receives Limited Approval for Osteoarthritis in Japan
SAN DIEGO & TOKYO Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that the use of Cytori Cell Therapy™ was approved for clinical use on June 24th, 2016 to treat knee osteoarthritis at...
View ArticleClik here to view.
サンバイオ、米国における外傷性脳損傷を対象としたフェーズ２臨床試験の被験者組み入れ開始のお知らせ
米国カリフォルニア州マウンテンビュー （ビジネスワイヤ） — 神経系疾患を対象に再生細胞薬の開発・製造を手掛ける当社グループ（サンバイオ株式会社及びその子会社であるSanBio, Inc.）...
View ArticleClik here to view.
First Patient is Randomized in STEMTRA Trial For Traumatic Brain Injury
MOUNTAIN VIEW, Calif. SanBio, Inc., a scientific leader in regenerative medicine for neurological disorders, today announced the randomization of the first patient in the STEMTRA Phase 2 clinical...
View ArticleClik here to view.
ASLAN Pharmaceuticals Enters Service Agreement with Selexis SA for...
GENEVA & SINGAPORE Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, and ASLAN Pharmaceuticals, a biotech company...
View ArticleClik here to view.
サンバイオ、シニア・バイスプレジデント（人事担当）にグレッグ・ギラスが就任
米国カリフォルニア州マウンテンビュー （ビジネスワイヤ） — 再生細胞薬の開発・製造を手掛けるサンバイオ（サンバイオ株式会社及びその子会社であるSanBio Inc.を含むサンバイオグループ2社を指します。）は、今般、シニア・バイスプレジデント（人事担当）にグレッグ・ギラス（Greg...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)...
View ArticleClik here to view.
サンバイオ、日本における外傷性脳損傷を対象としたフェーズ２臨床試験開始のお知らせ
東京 （ビジネスワイヤ） — サンバイオ株式会社（本社:東京都中央区、代表取締役社長：森 敬太）は、本日、神経系疾患を対象に日米で開発を進めている再生細胞薬SB623（以下、「本剤」）の外傷性脳損傷を対象としたフェーズ２臨床試験を国内で開始しましたので、お知らせします。...
View ArticleClik here to view.
SanBio Begins Clinical Trial of Regenerative Cell Medicine for Patients with...
MOUNTAIN VIEW, Calif. SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, announced today that it has begun a Phase 2 clinical trial of regenerative cell...
View ArticleClik here to view.
Xcell Biosciences Announces Two New International Distributors and Multiple...
SAN FRANCISCO Xcell Biosciences, Inc., today announced it has signed agreements with two international distributors and made a number of international sales for its Avatar™ system. Cambridge...
View ArticleClik here to view.
IVF-Worldwide.com Launches Virtual Academy of Egg Health
HONG KONG & SALT LAKE CITY Today, at the American Society for Reproductive Medicine (ASRM) 2016 Scientific Congress & Expo, IVF-Worldwide, the largest and most comprehensive in-vitro...
View ArticleClik here to view.
Takeda Showcases Continued Commitment in Hodgkin Lymphoma During 10th...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) will present data on ADCETRIS® (brentuximab vedotin) in Hodgkin lymphoma at the 10th International Symposium on...
View ArticleClik here to view.
サンバイオ、日本における外傷性脳損傷を対象としたフェーズ２臨床試験の被験者組み入れ開始のお知らせ
東京 （ビジネスワイヤ） — サンバイオ株式会社（本社:東京都中央区、代表取締役社長：森...
View Article